Chemical Synthesis and Separation
The development and manufacture of APIs and regulated intermediates are among the core competencies of EMD. In compliance with the requirements for biopharmaceutical APIs, we provide various synthetic lipid specialties and PEG derivatives as components for customized drug delivery systems. We cooperate intensively with our customers to guarantee a reliable supply of their innovative product during phase I-III clinical trials and in scale-up to production in the post-approval phase. EMD offers its customers high quality and reproducibility as well as extensive support in regulatory issues.
